June 18, 2015 | Pluristem Therapeutics, an Israeli company developing placenta-based therapy products, announced that it was awarded a NIS 11 million (approx. $2.9 million) from the Office of the Chief Scientist. The grant will go towards research and development for 2015. Pluristem was founded in 2001 by Shai Meretzki.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments